Aprotinin - a New Drug Candidate for The Prevention of SARS-CoV-2 (COVID-19)

ПРЕПРИНТ

Эта статья является препринтом и не была отрецензирована.
О результатах, изложенных в препринтах, не следует сообщать в СМИ как о проверенной информации.

Ivashchenko A. A.,

Svistunov A. A.,

Khorobryh T. V.,

Loginov V. G.,

Karapetian R. N.,

Mishchenko N. P.,

Poyarkov S. V.,

Volgin M. V.,

Yakubova E. V.,

Topr M. P.,

Pyankov O. V.,

Magerramova A. V.,

Tomilov A. A.,

Ivashchenko A. V.

2020-09-13

https://doi.org/10.21055/preprints-3111813

The efficacy of Aprotinin as prophylactic treatment of Covid-19 was studied in the hamster model of SARS-CoV-2 and in the health care personnel working with Covid-19 patients in hospital. High efficacy of Aprotinin in pre- and post-exposure prophylaxis of SARS-CoV-2 was demonstrated.

Ссылка для цитирования:

Ivashchenko A. A., Svistunov A. A., Khorobryh T. V., Loginov V. G., Karapetian R. N., Mishchenko N. P., Poyarkov S. V., Volgin M. V., Yakubova E. V., Topr M. P., Pyankov O. V., Magerramova A. V., Tomilov A. A., Ivashchenko A. V. 2020. Aprotinin - a New Drug Candidate for The Prevention of SARS-CoV-2 (COVID-19). COVID19-PREPRINTS.MICROBE.RU. https://doi.org/10.21055/preprints-3111813

Список литературы

1. Russian Federation first registered vaccine from coronavirus. Interfax.RU August 11 2020. https://www.interfax.ru/news/2020/08/11. https://sia.ru/?section=484&action=show_news&id=399342

2. Prevention and Prophylaxis of SARS-CoV-2 Infection. Last Updated: July 17, 2020. Available at: https://www.covid19treatmentguidelines.nih.gov/ overview/prevention-of-sars-cov-2/.

3. Bojkova D, McGreig JE, McLaughlin K-M, Masterson SG, Widera M, Krahling V, Ciesek S, Wass MN, Michaelis M, Cinati jr J. SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles. BioRxiv, doi: https://doi.org/10.1101/2020.04.03.024257.

4. Bestle D, Heindl MR, Limburg H, et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance. 2020;3(9):e202000786. Published 2020 Jul 23. doi:10.26508/lsa.202000786

5. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8. doi:10.1016/j.cell.2020.02.052

6. Bugge TH, Antalis TM, Wu Q. Type II transmembrane serine proteases. 2009. J Biol Chem

7. 284:23177-81. Review.

8. Böttcher-Friebertshäuser E. 2018. Membrane-Anchored Serine Proteases: Host Cell Factors in Proteolytic Activation of Viral Glycoproteins. In: Böttcher-Friebertshäuser E., Garten W., Klenk H. (eds) Activation of Viruses by Host Proteases. Springer, Cham, p.153-203. Review

9. Hoffmann M, Hofmann-Winkler H, Pöhlmann S. 2018. Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins. In: Böttcher-Friebertshäuser E., Garten W., Klenk H. (eds) Activation of Viruses by Host Proteases. Springer, Cham, p.71-98. Review

10. Moggia E, Koti R, Belgaumkar AP, Fazio F, Pereira SP, Davidson BR, Gurusamy KS.Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev.2017 Apr 21;4:CD011384.

11. Kapadia BH, Torre BB, Ullman N, Yang A, Harb MA, Grieco PW, Newman JM, Harwin SF, Maheshwari AV. Reducing perioperative blood loss with antifibrinolytics and antifibrinolytic-like agents for patients undergoing total hip and total knee arthroplasty. Orthop. 2019 Jul 2;16(6):513-516.

13. O.P. Zhirnov, H. D. Klenk, P. F. Wright. Aprotinin and similar protease inhibitors as drugs against influenza. Antiviral. Res. 2011, 92(1), 27-36. doi: 10.1016/j.antiviral.2011.07.014

14. O. P. Zhirnov, P. B. Golyando, A. V. Ovcharenko. Replication of Influenza B virus in chicken embryos is suppressed by exogenous aprotinin. Archives of Virology 1994, 135, 209–216. https://doi.org/10.1007/BF01309780

15. Ovcharenko, A. V., & Zhirnov, O. P. (1994). Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. Antiviral research, 23(2), 107-118. https://doi.org/10.1016/0166-3542(94)90038-8.

16. Ovcharenko, A. V., & Zhirnov, O. P. (1994). Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. Antiviral research, 23(2), 107-118. https://doi.org/10.1016/0166-3542(94)90038-8.

17. Shen LW, Mao HJ, Wu YL, Tanaka Y, Zhang W. TMPRSS2: A potential target for

18. treatment of influenza virus and coronavirus infections. Biochimie. 2017 Nov;142:1-10.

19. Medical prophylaxis of COVID-19 in adults. Temporary recommendations. Prophylaxis, Diagnosis and Therapy of Novel Coronavirus Infection (COVID-19). Ministry of Health Russian Federation, Version 7, p.71 (03.06.2020).

20. https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/ 03062020_%D0%9CR_COVID-19_v7.pdf.

ПРЕПРИНТ

ИНФОРМАЦИЯ О ПРЕПРИНТЕ